Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease

Benzer Materyaller

• Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo
  Yazar:: Svarcbahs, Reinis, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Molecular and structural architecture of polyQ aggregates in yeast
  Yazar:: Gruber, Anselm, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Distribution of Prolyl Oligopeptidase in Human Peripheral Tissues and in Ovarian and Colorectal Tumors
  Yazar:: Myöhänen, Timo T., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI(+)] prion in yeast and aggregation of Sup35 in vitro
  Yazar:: Derkatch, Irina L., ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Ataxin-1 Fusion Partners Alter PolyQ Lethality and Aggregation
  Yazar:: Rich, Tina, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)